Relmada Therapeutics
RLMD
#9904
Rank
C$16.46 M
Marketcap
$0.55
Share price
4.60%
Change (1 day)
-87.45%
Change (1 year)

Market capitalization of Relmada Therapeutics (RLMD)

Market cap: C$16.46 Million

As of December 2024 Relmada Therapeutics has a market cap of C$16.46 Million. This makes Relmada Therapeutics the world's 9904th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Relmada Therapeutics from 2014 to 2024

End of year Market Cap

Year Marketcap Change
2024C$16.46 M-90.04%
2023C$0.16 B15.95%
2022C$0.14 B-82.1%
2021C$0.79 B19.26%
2020C$0.66 B-9.3%
2019C$0.73 B1479.33%
2018C$46.62 M294.2%
2017C$11.82 M-32.91%
2016C$17.62 M-57.64%
2015C$41.61 M-78.45%
2014C$0.19 B

End of Day market cap according to different sources

On Dec 22nd, 2024 the market cap of Relmada Therapeutics was reported to be:

C$15.73 Million
by Nasdaq info icon info icon
C$15.73 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
C$2.32 B 13,999.81%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
C$8.30 B 50,334.10%๐Ÿ‡บ๐Ÿ‡ธ USA